Does China Have Any Comparative Advantages? If So, How to Counter Them.
The U.S. China Economic and Security Review Commission asked panelists to discuss just how powerful, and important, China supply chains have become to the U.S. economy.
New Thinking Needed on Supply Chain Resilience
The U.S. China Economic and Security Review Commission heard from panelists this week on Washington’s reshoring efforts. Question: Will there be any buyers?
U.S. Farmers Seen as Major Linchpin to U.S.-Asia Trade
U.S. farmer associations push for more trade deals in Senate hearing on agriculture.
Following Solar Debacle, Republicans Come Out Swinging on China
The Republican-led China Task Force held an impromptu meeting Wednesday, where they backed stronger export and capital controls if they win back the House.
U.S. Trade Deficit Eases in April, Down 19.1% to $87.1 Billion
The trade deficit fell. But the January-April goods deficit is still another record breaker.
Biden Just Went Against His Voters, Sided with China on Solar
Voters support locally made solar. So why is the Biden administration giving China companies under investigation for trade violations in SE Asia duty-free access to the U.S.?
FDA’s Updated Drug Shortage List Loaded with Critical Medicines
The Food and Drug Administration recently updated its drug shortage list. More than half of the updates include drugs on the essential medicines list.
Pharma and Trade Deals Top of Mind in China Commission Hearing
The U.S. China Economic and Security Review Commission discussed the tight-linked China-India pharmaceutical supply chain, and tossed aside the notion that sweeping trade deals with India and the region are good ideas.
Senate Intelligence Hearing on China: “Run Faster and Slow Them Down.”
The Senate Intelligence Committee discusses China’s strategy for economic and technological dominance. Senator Marco Rubio wonders if China will hold supply chains hostage.
FDA Funding Bill Heads to Final Committee, With One Major Stumbling Block
The Health subcommittee of the House Energy and Commerce Committee have moved the FDA user-fee reauthorization bill to final committee. Chairwoman Eshoo says it is on track for September approval.
